GlassScriptPhysician profile
Arnold W Fleischmann
NPI 1487825808
$1,736.35
in general payments reported to CMS, 2019-2025
16 companies · $378 in 2025
The $378 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $486 · 2020: $94.33 · 2021: $164 · 2022: $145 · 2023: $209 · 2024: $259 · 2025: $378.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $846.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $846.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $498.82 | 2019-2025 | Trelegy Ellipta, Arexvy |
| Novo Nordisk INC | $222.73 | 2019-2025 | Ozempic |
| Astrazeneca Pharmaceuticals LP | $195.40 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Amgen INC. | $158.82 | 2023-2025 | Repatha, Otezla, Krystexxa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $105.18 | 2023-2025 | Jardiance |
| Novartis Pharmaceuticals Corporation | $94.83 | 2019-2023 | |
| Astellas Pharma US INC | $87.54 | 2019-2020 | |
| Exact Sciences Corporation | $80.40 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Sanofi-Aventis U.S. LLC | $65.82 | 2019 | |
| Pfizer INC. | $53.77 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $50.60 | 2021-2024 | |
| Janssen Pharmaceuticals, INC | $38.16 | 2019-2021 | |
| Lilly USA, LLC | $36.50 | 2024-2025 | Mounjaro, Jardiance |
| Abbott Laboratories | $18.03 | 2021 | |
| Merck Sharp & Dohme LLC | $15.10 | 2025 | Capvaxive |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $14.65 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arnold Fleischmann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.